An observational study in Sepsis Due to Streptococcus, Group A, Risk Factors and Severe Infection, sponsored by Association Clinique Thérapeutique Infantile du val de Marne. Recruiting at 1 site in France. Open to participants aged 1 Day to 17 Years. Per ClinicalTrials.gov, last updated 2024-02-08.
Sponsored by Association Clinique Thérapeutique Infantile du val de Marne · Observational
This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection
The main of this study is to identify and record cases of invasive and severe infections due to Streptococcus pyogenes. In order to evaluate the incidence of severe forms of disease and the possible contributing factors, and to optimize their management.
Admitted patients to intensive care or critical care units in reported via Santé Publique France may also be included in this study.
Secondly, epidemiological, clinical, bacteriological data of all severe or not cases, of group A Streptococcal infections will be compiled to describe their characteristics, and try to explain this recrudescence as well as possible.
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's planned enrollment of 100 is below the median of 240 across 2,136 observational studies indexed under Infections.
Browse Infections studies →Association Clinique Thérapeutique Infantile du val de Marne is the lead sponsor of 15 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pediatrics patients with documented invasive infection due to Group A Streptococcus
Exclusion Criteria:
Hospitalisation
How long patient was hospitalised during this infection
Time frame: 1 year
Treatments provided in intensive care unit
what treatments are used in intensive care unit to treat infection
Time frame: 1 year
Complications
what are the complications due to severe infection
Time frame: 1 year
Treatments used in routine care unit
which treatments are used in routine care unit to treat the infection
Time frame: 1 year
Risk factors
description of underlying conditions
Time frame: 1 year
Characterization of Group A Streptococcus strains
Characterization of Group A Streptococcus strains by the CNR
Time frame: 1 year
Death
Death Outcome during hospitalisation
Time frame: 1 year
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Association Clinique Thérapeutique Infantile du val de Marne